Pictet Asset Management’s Celldex Therapeutics CLDX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $26.5M | Buy |
1,300,329
+342,535
| +36% | +$6.97M | 0.03% | 437 |
|
|
2025
Q1 | $17.4M | Sell |
957,794
-132,379
| -12% | -$2.4M | 0.02% | 531 |
|
|
2024
Q4 | $27.5M | Sell |
1,090,173
-48,273
| -4% | -$1.22M | 0.03% | 417 |
|
|
2024
Q3 | $38.7M | Sell |
1,138,446
-245,234
| -18% | -$8.34M | 0.04% | 339 |
|
|
2024
Q2 | $51.2M | Sell |
1,383,680
-111,275
| -7% | -$4.12M | 0.06% | 278 |
|
|
2024
Q1 | $62.7M | Sell |
1,494,955
-730,493
| -33% | -$30.7M | 0.07% | 269 |
|
|
2023
Q4 | $88.3M | Buy |
2,225,448
+374,478
| +20% | +$14.9M | 0.1% | 217 |
|
|
2023
Q3 | $50.9M | Buy |
+1,850,970
| New | +$50.9M | 0.06% | 284 |
|